换一批
换一批Economic consequence of switching to citalopram after its generic entry for adult patients with major depressive disorder (MDD) treated with escitalopram: a 6-month retrospective study.
作者：
主题词
成年人(Adult);抗抑郁药, 第二代(Antidepressive Agents, Second-Generation);西酞普兰(Citalopram);共病现象(Comorbidity);抑郁症, 更年期(Depressive Disorder, Major);费用, 药物(Fees, Pharmaceutical);女(雌)性(Female);卫生服务(Health Services);住院(Hospitalization);人类(Humans);保险范围(Insurance Coverage);保险, 健康(Insurance, Health);男(雄)性(Male);中年人(Middle Aged);回顾性研究(Retrospective Studies)
DOI
10.3111/13696998.2010.521736
PMID
20879834
发布时间
2018-12-01
- 浏览16
Journal of medical economics
599-609页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
